[1] SINAL C J,TOHKIN M,MIYATA M,et al.Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis[J].Cell,2000,102(6):731-744. [2] MASSAFRA V,VAN M S.Farnesoid X receptor:A "homeostat" for hepatic nutrient metabolism[J].2018,1864(1):45-59. [3] WANG H,CHEN J,HOLLISTER K,et al.Endogenous bile acids are ligands for the nuclear receptor FXR/BAR[J].Cell,1999,3(5):543-553. [4] HOU Y,FAN W,YANG W,et al.Farnesoid X receptor:An important factor in blood glucose regulation[J].Clinica Chimica Acta,2019,495:29-34. [5] 徐俐洁,蒋思达,季晖,等.胆汁酸核受体FXR在胆汁淤积及其药物治疗中的研究进展[J].药学研究,2018,37(3):169-173. XU L J,JIANG S D,JI H,et al.Role of bile acid nuclear receptor FXR in cholestasis and related pharmacotherapy[J].Journal of Pharmaceutical Research,2018,37(3):169-173. [6] ZHANG Y,LEE F Y,BARRERA G,et al.Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipid-emia in diabetic mice[J].Proceedings of the National Academy of Sciences of the United States of America,2006,103(4):1006-1011. [7] ROMEO S.Notch and nonalcoholic fatty liver and fibrosis[J].The New England Journal of Medicine,2019,380(7):681-683. [8] YUAN A,MA X,He B,et al.Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury[J].European Heart Journal:The Journal of the European Society of Cardiology,2013,34(24):1834-1845. [9] SWALES K E,KORBONITS M,CARPENTER R,et al.The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expre-ssion[J].Cancer Research,2006,66(20):10120-10126. [10] JOSE J M,MARIA J M,ALBA G B,et al.The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy[J].Acta Pharmacologica Sinica,2014,35(1):1-10. [11] YU H,GUANG Q L,JIN Z D,et al.Comparison and optimization of CRISPR/dCas9/gRNA genome-labeling systems for live cell imaging[J].Genome Biology,2018,19(1):39. [12] BARRANGOU R,FREMAUX C,DEVEAU H,et al.CRISPR provides acquired resistance against viruses in prokaryotes[J].Science,2007,315(5819):1709-1712. [13] PLAZA R A,LANNER F.Towards a CRISPR view of early human development:Applications,limitations and ethical concerns of genome editing in human embryos[J].Development,2017,144(1):3-7. [14] GARNEAU J,DUPUIS M,VILLION M,et al.The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA[J].Nature,2010,468(7320):67-71. [15] DELTCHEVA E,CHYLINSKI K,SHARMA C,et al.CRISPR RNA maturation by trans-encoded small RNA and host factor RNase Ⅲ[J].Nature,2011,471(7340):602-607. [16] HORII T,HATADA I.Genome editing using mammalian haploid cells[J].International Journal of Molecular Science,2015,16(10):23604-23614. [17] MODICA S,BELLAFANTE E,MOSCHETTA A.Master regulation of bile acid and xenobiotic metabolism via the FXR,PXR and CAR trio[J].Frontiers in Bioscience (Landmark Edition),2009,14:4719-4745. [18] MIYATA M,SAKAIDA Y,MATSUZAWA H,et al.Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice[J].Biological & Pharmaceutical Bulletin,2011,34(12):1885-1889. [19] EVANS M J,MAHANEY P E,BORGES-MARCUCCI L,et al.A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia[J].American Journal of Physiology-Gastrointest and Liver Physiology,2009,296(3):G543-G552. [20] GAUTIER T,DE H W,GROBER J,et al.Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice[J].Journal of Lipid Research,2013,54(8):2195-2205. [21] DENG Y,WANG H,LU Y,et al.Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis[J].Endocrinology,2013,154(5):1794-1801. [22] LIU X,WANG M,QIN Y,et al.Targeted integration in human cells through single crossover mediated by ZFN or CRISPR/Cas9[J].BMC Biotechnology,2018,18(1):66. [23] HE Z,PROUDFOOT C,WHITELAW C B A,et al.Comparison of CRISPR/Cas9 and TALENs on editing an integrated EGFP gene in the genome of HEK293T cells[J].Springerplus,2016,5(1):814. [24] MALI P,YANG L,ESVELT K M,et al.RNA-guided human genome engineering via Cas9[J].Science,2013,339(6121):823-826. [25] GILBERT L A,LARSON M H,MORSUT L,et al.CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes[J].Cell,2013,154(2):442-451. [26] LONE B A,KARNA S,AHMAD F,et al.CRISPR/Cas9 system:A bacterial tailor for genomic engineering[J].Genetics and Molecular Research,2018,2018:3797214. [27] WANG H,YANG H,SHIYALILA C S,et al.One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering[J].Cell,2013,153(4):910-918. [28] 王姗姗,杨军,王中,等.利用CRISPR/Cas9技术的烟草NtLS基因敲除分析[J].烟草科技,2018,51(2):1-8. WANG S S,YANG J,WANG Z,et al.Targeted mutagenesis of NtLS gene using CRISPR/Cas9 system[J].Tobacco Science & Technology,2018,51(2):1-8.(in Chinese) [29] PLATT R J.CRISPR-Cas9 knockin mice for genome editing and cancer modeling[J].Cell,2014,159(2):440-455. |